Novartis revenue 2014-2023 by segment

Novartis AG's revenue from 2014 to 2023, by segment

Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

January 2024

Region

Worldwide

Survey time period

2014 to 2023

Supplementary notes

This statistic was assembled from several Novartis' annual reports. All figures are rounded.
* In 2015, a joint venture between Novartis OTC and GSK Consumer Healthcare was formed.
** In 2015, the vaccines business was sold to GSK.
*** During 2019, eye care division Alcon was spun off and became an own company. Thus, Alcon's revenues are not included from this year onwards.
**** The spin-off of Sandoz brought changes in the structure of segments: Innovative Medicines became "Promoted brands" and the rest "Established brands".

Open this statistic in...
Citation formats
Statista Accounts: Access All Statistics. Starting from $2,148 USD / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$199 USD $179 USD / Month *
in the first 12 months
Professional Account
Full access

Business Solutions including all features.

* Prices do not include sales tax.

Statistics on " Novartis "

Other statistics that may interest you Novartis

Overview

6

Financials

5

Segments

4

Competitors

6

Research and development

4

Outlook

4

Further related statistics

18
Statista Accounts: Access All Statistics. Starting from $2,148 USD / Year
Learn more about how Statista can support your business.